⌘K

Login Start Free

Home/Filings/4/0001104659-21-011848

4//SEC Filing

HANCOCK THOMAS 4

Accession 0001104659-21-011848

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:52 PM ET

Size

5.4 KB

Accession

0001104659-21-011848

Insider Transaction Report

Form 4

Period: 2021-02-01

EYEGATE PHARMACEUTICALS INCEYEG

Director

Transactions

Award
Stock Option (right to buy)
2021-02-01+3,333→ 3,333 total
Exercise: $6.46Exp: 2031-02-01→ Common Stock (3,333 underlying)

Footnotes (1)

[F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2022.

Documents

1 file

4
tm215262-6_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001619727

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 9:52 PM ET
Size: 5.4 KB

View on SEC.gov